Paradigm shifts in newborn screening?

Affiliations

¹ New England Newborn Screening Program and the Department of Pediatrics, University of Massachusetts Medical School, Worcester, Massachusetts, USA. anne.comeau@umassmed.edu.

Comment

Anne Marie Comeau. Genet Med. 2019 Mar.

. 2019 Mar;21(3):534-535.

doi: 10.1038/s41436-018-0130-5. Epub 2018 Aug 10.

¹ New England Newborn Screening Program and the Department of Pediatrics, University of Massachusetts Medical School, Worcester, Massachusetts, USA. anne.comeau@umassmed.edu.

No abstract available

Comment on

The New York pilot newborn screening program for lysosomal storage diseases: Report of the First 65,000 Infants.
Wasserstein MP, Caggana M, Bailey SM, Desnick RJ, Edelmann L, Estrella L, Holzman I, Kelly NR, Kornreich R, Kupchik SG, Martin M, Nafday SM, Wasserman R, Yang A, Yu C, Orsini JJ. Wasserstein MP, et al. Genet Med. 2019 Mar;21(3):631-640. doi: 10.1038/s41436-018-0129-y. Epub 2018 Aug 10. Genet Med. 2019. PMID: 30093709 Free PMC article.

1. Wasserstein MP, Caggana M, Bailey SM, et al. The New York pilot newborn screening program for lysosomal storage diseases: Report of the First 65,000 Infants. Genet Med. 2018. https://doi.org/10.1038/s41436-018-0129-y - DOI
1. Guthrie R, Susi A. Simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants. Pediatrics. 1963;32:338–343. - PubMed
1. MacCready RA, Hussey MG. Newborn phenylketonuria detection program in Massachusetts. Am J Public Health Nations Health. 1964;54:2075–2081. - DOI
1. Comeau AM, Larson C, Eaton RB. Integration of new genetic diseases into statewide newborn screening: New England experience. Am J Med Genet C Semin Med Genet. 2004;125C:35–41. - DOI
1. Caggana M, Jones EA, Shahied SI, et al. Newborn screening: from Guthrie to whole genome sequencing. Public Health Rep. 2013;128(suppl 2):14–19. - DOI